These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17240317)

  • 1. Urokinase-type plasminogen activator deficiency (uPA-KO) prevented carotid artery ligation-induced vascular remodeling in mice.
    Martin-McNulty B; Zhang L; da Cunha V; Vincelette J; Rutledge JC; Vergona R; Sullivan ME; Wang YX
    Transl Res; 2007 Feb; 149(2):70-5. PubMed ID: 17240317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm.
    Deng GG; Martin-McNulty B; Sukovich DA; Freay A; Halks-Miller M; Thinnes T; Loskutoff DJ; Carmeliet P; Dole WP; Wang YX
    Circ Res; 2003 Mar; 92(5):510-7. PubMed ID: 12600880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte chemoattractant protein-1 or macrophage inflammatory protein-1alpha deficiency does not affect angiotensin II-induced intimal hyperplasia in carotid artery ligation model.
    Zhang LN; da Cunha V; Martin-McNulty B; Rutledge J; Vergona R; Sullivan ME; Wang YX
    Cardiovasc Pathol; 2007; 16(4):231-6. PubMed ID: 17637431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation.
    Zhang LN; Wilson DW; da Cunha V; Sullivan ME; Vergona R; Rutledge JC; Wang YX
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):765-72. PubMed ID: 16456092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model.
    Li Y; Minamino T; Tsukamoto O; Yujiri T; Shintani Y; Okada K; Nagamachi Y; Fujita M; Hirata A; Sanada S; Asanuma H; Takashima S; Hori M; Johnson GL; Kitakaze M
    Circulation; 2005 Apr; 111(13):1672-8. PubMed ID: 15795331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
    Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase plasminogen activator in injured adventitia increases the number of myofibroblasts and augments early proliferation.
    Plekhanova OS; Stepanova VV; Ratner EI; Bobik A; Tkachuk VA; Parfyonova YV
    J Vasc Res; 2006; 43(5):437-46. PubMed ID: 16899994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening.
    Korshunov VA; Berk BC
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2185-91. PubMed ID: 14576075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-beta attenuates angiotensin II-accelerated atherosclerosis and vascular remodeling in apolipoprotein E deficient mice.
    Zhang LN; Velichko S; Vincelette J; Fitch RM; Vergona R; Sullivan ME; Croze E; Wang YX
    Atherosclerosis; 2008 Mar; 197(1):204-11. PubMed ID: 17466308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting effects of urokinase and tissue-type plasminogen activators on neointima formation and vessel remodelling after arterial injury.
    Parfyonova Y; Plekhanova O; Solomatina M; Naumov V; Bobik A; Berk B; Tkachuk V
    J Vasc Res; 2004; 41(3):268-76. PubMed ID: 15192267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10 fails to modulate low shear stress-induced neointimal hyperplasia.
    Rectenwald JE; Minter RM; Moldawer LL; Abouhamze Z; La Face D; Hutchins E; Huber TS; Seeger JM; Ozaki CK
    J Surg Res; 2002 Feb; 102(2):110-8. PubMed ID: 11796006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased bone formation in mice lacking plasminogen activators.
    Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
    J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator.
    Schäfer K; Konstantinides S; Riedel C; Thinnes T; Müller K; Dellas C; Hasenfuss G; Loskutoff DJ
    Circulation; 2002 Oct; 106(14):1847-52. PubMed ID: 12356640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of urokinase plasminogen activator promotes progression and instability of atherosclerotic lesions in apolipoprotein E-knockout mice.
    Dellas C; Schremmer C; Hasenfuss G; Konstantinides SV; Schäfer K
    Thromb Haemost; 2007 Jul; 98(1):220-7. PubMed ID: 17598016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligonucleotide microarrays reveal regulated genes related to inward arterial remodeling induced by urokinase plasminogen activator.
    Plekhanova O; Berk BC; Bashtrykov P; Brooks AI; Tkachuk V; Parfyonova Y
    J Vasc Res; 2009; 46(3):177-87. PubMed ID: 18812699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type mice: cellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals.
    Shapiro RL; Duquette JG; Roses DF; Nunes I; Harris MN; Kamino H; Wilson EL; Rifkin DB
    Cancer Res; 1996 Aug; 56(15):3597-604. PubMed ID: 8758932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombomodulin plays an important role in arterial remodeling and neointima formation in mouse carotid ligation model.
    Li YH; Liu SL; Shi GY; Tseng GH; Liu PY; Wu HL
    Thromb Haemost; 2006 Jan; 95(1):128-33. PubMed ID: 16543971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase-type plasminogen activator regulates neurodegeneration and neurogenesis but not vascular changes in the mouse hippocampus after status epilepticus.
    Lahtinen L; Ndode-Ekane XE; Barinka F; Akamine Y; Esmaeili MH; Rantala J; Pitkänen A
    Neurobiol Dis; 2010 Mar; 37(3):692-703. PubMed ID: 20026272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II induces histomorphologic features of unstable plaque in a murine model of accelerated atherosclerosis.
    da Cunha V; Martin-McNulty B; Vincelette J; Choy DF; Li WW; Schroeder M; Mahmoudi M; Halks-Miller M; Wilson DW; Vergona R; Sullivan ME; Wang YX
    J Vasc Surg; 2006 Aug; 44(2):364-71. PubMed ID: 16890870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
    Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
    Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.